RELATED STUDY

Chronic treatment with the phytocannabinoid Cannabidivarin (CBDV) rescues behavioural alterations and brain atrophy in a mouse model of Rett syndrome

Key Findings:  This animal study of the endocannabinoid system (ECS) and Rett syndrome (RTT) further delineates the role of the ECS in physiological and behavioral symptoms related to RTT and presents G protein-coupled receptors and cannabidivarin (CBDV)as new potential therapeutic targets for novel treatments of this disorder.